Identification of genetic fingerprint of type I interferon therapy in visceral metastases of melanoma
Abstract Malignant melanoma is a difficult-to-treat skin cancer with increasing incidence worldwide. Although type-I interferon (IFN) is no longer part of guidelines, several melanoma patients are treated with type-I interferon (IFN) at some point of the disease, potentially affecting its genetic pr...
Saved in:
| Main Authors: | Laura Vízkeleti, Orsolya Papp, Viktória Doma, Jeovanis Gil, György Markó-Varga, Szonja A. Kovács, Balázs Győrffy, Sarolta Kárpáti, József Tímár |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-77285-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A
by: Kata Ferenczi, et al.
Published: (2025-05-01) -
Visceral Obesity: Terminology, Measurement, and Its Correlation with Inflammation
by: Anna A. Tarabrina, et al.
Published: (2022-10-01) -
VISCERAL ADIPOSITY AS A GLOBAL FACTOR OF CARDIOVASCULAR RISK
by: G. A. Chumakova, et al.
Published: (2018-06-01) -
The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-01-01) -
Prediction Value of Visceral Obesity Related Indices for Visceral Obesity in Chinese Patients with Type 2 Diabetes Mellitus
by: Tan Y, et al.
Published: (2025-06-01)